skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Results 1 - 20 of 24,062  for All Library Resources

Results 1 2 3 4 5 next page
Show only
Result Number Material Type Add to My Shelf Action Record Details and Options
1
1. Molecular Target Drug Discovery
Material Type:
Article
Add to My Research

1. Molecular Target Drug Discovery

Internal Medicine, 2007, Vol.46(2), pp.87-90 [Peer Reviewed Journal]

2007 by The Japanese Society of Internal Medicine ;ISSN: 0918-2918 ;EISSN: 1349-7235 ;DOI: 10.2169/internalmedicine.46.1779 ;PMID: 17220605

Full text available

2
100% Human Monoclonal Antibodies in Oncology: Hype or Breakthrough?
Material Type:
Article
Add to My Research

100% Human Monoclonal Antibodies in Oncology: Hype or Breakthrough?

Current topics in medicinal chemistry, 2012-08, Vol.12 (15), p.1643-1648 [Peer Reviewed Journal]

ISSN: 1568-0266 ;DOI: 10.2174/156802612803531351

Full text available

3
10th antibody industrial symposium: new developments in antibody and adoptive cell therapies
Material Type:
Article
Add to My Research

10th antibody industrial symposium: new developments in antibody and adoptive cell therapies

mAbs, 2023-12, Vol.15 (1), p.2211692-2211692 [Peer Reviewed Journal]

Attribution - NonCommercial ;2023 The Author(s). Published with license by Taylor & Francis Group, LLC. 2023 The Author(s) ;ISSN: 1942-0862 ;EISSN: 1942-0870 ;DOI: 10.1080/19420862.2023.2211692 ;PMID: 37184206

Full text available

4
(111)In-labeled trastuzumab (Herceptin) modified with nuclear localization sequences (NLS): an Auger electron-emitting radiotherapeutic agent for HER2/neu-amplified breast cancer
Material Type:
Article
Add to My Research

(111)In-labeled trastuzumab (Herceptin) modified with nuclear localization sequences (NLS): an Auger electron-emitting radiotherapeutic agent for HER2/neu-amplified breast cancer

The Journal of nuclear medicine (1978), 2007-08, Vol.48 (8), p.1357 [Peer Reviewed Journal]

ISSN: 0161-5505 ;EISSN: 1535-5667 ;DOI: 10.2967/jnumed.106.037937 ;PMID: 17631548

Full text available

5
11C-PiB PET assessment of change in fibrillar amyloid-β load in patients with Alzheimer's disease treated with bapineuzumab: a phase 2, double-blind, placebo-controlled, ascending-dose study
Material Type:
Article
Add to My Research

11C-PiB PET assessment of change in fibrillar amyloid-β load in patients with Alzheimer's disease treated with bapineuzumab: a phase 2, double-blind, placebo-controlled, ascending-dose study

Lancet neurology, 2010-04, Vol.9 (4), p.363-372 [Peer Reviewed Journal]

2010 Elsevier Ltd ;2010 Elsevier Ltd. All rights reserved. ;ISSN: 1474-4422 ;ISSN: 1474-4465 ;EISSN: 1474-4465 ;DOI: 10.1016/S1474-4422(10)70043-0 ;PMID: 20189881

Full text available

6
131I-anti CD20 radioimmunotherapy of relapsed or refractory non-Hodgkins lymphoma: A Phase II Clinical trial of a nonmyeloablative dose regimen of chimeric rituximab radiolabeled in a hospital
Material Type:
Article
Add to My Research

131I-anti CD20 radioimmunotherapy of relapsed or refractory non-Hodgkins lymphoma: A Phase II Clinical trial of a nonmyeloablative dose regimen of chimeric rituximab radiolabeled in a hospital

Cancer biotherapy & radiopharmaceuticals, 2003-08, Vol.18 (4), p.513-524 [Peer Reviewed Journal]

2004 INIST-CNRS ;ISSN: 1084-9785 ;EISSN: 1557-8852 ;PMID: 14503945 ;CODEN: CBRAFJ

Full text available

7
131I-anticarcinoembryonic antigen therapy of LS174T human colon adenocarcinoma spheroids
Material Type:
Article
Add to My Research

131I-anticarcinoembryonic antigen therapy of LS174T human colon adenocarcinoma spheroids

Cancer research (Chicago, Ill.), 1989-06, Vol.49 (12), p.3401-3406 [Peer Reviewed Journal]

1989 INIST-CNRS ;ISSN: 0008-5472 ;EISSN: 1538-7445 ;PMID: 2720694 ;CODEN: CNREA8

Full text available

8
131I-labelled anti-CD22 MAb (LL2) in patients with B-cell lymphomas failing chemotherapy: Treatment outcome, haematological toxicity and bone marrow absorbed dose estimates
Material Type:
Article
Add to My Research

131I-labelled anti-CD22 MAb (LL2) in patients with B-cell lymphomas failing chemotherapy: Treatment outcome, haematological toxicity and bone marrow absorbed dose estimates

Acta oncologica, 2002, Vol.41 (3), p.297-303 [Peer Reviewed Journal]

2002 INIST-CNRS ;ISSN: 0284-186X ;ISSN: 1651-226X ;EISSN: 1651-226X ;DOI: 10.1080/02841860260088854 ;PMID: 12195750 ;CODEN: ACTOEL

Full text available

9
131I Radioimmunotherapy and Fractionated External Beam Radiotherapy: Comparative Effectiveness in a Human Tumor Xenograft
Material Type:
Article
Add to My Research

131I Radioimmunotherapy and Fractionated External Beam Radiotherapy: Comparative Effectiveness in a Human Tumor Xenograft

The Journal of nuclear medicine (1978), 1999-10, Vol.40 (10), p.1764-1768 [Peer Reviewed Journal]

1999 INIST-CNRS ;ISSN: 0161-5505 ;EISSN: 1535-5667 ;PMID: 10520720

Full text available

10
131I-Rituximab: Relationship Between Immunoreactivity and Specific Activity
Material Type:
Article
Add to My Research

131I-Rituximab: Relationship Between Immunoreactivity and Specific Activity

The Journal of nuclear medicine (1978), 2004-10, Vol.45 (10), p.1784-1790 [Peer Reviewed Journal]

ISSN: 0161-5505 ;EISSN: 1535-5667 ;PMID: 15471849

Full text available

11
131I-Tositumomab (Bexxar) vs. 90Y-Ibritumomab (Zevalin) therapy of low-grade refractory/relapsed non-Hodgkin lymphoma
Material Type:
Article
Add to My Research

131I-Tositumomab (Bexxar) vs. 90Y-Ibritumomab (Zevalin) therapy of low-grade refractory/relapsed non-Hodgkin lymphoma

Molecular imaging and biology, 2010-04, Vol.12 (2), p.198-203 [Peer Reviewed Journal]

Academy of Molecular Imaging and Society for Molecular Imaging 2010 ;ISSN: 1536-1632 ;EISSN: 1860-2002 ;DOI: 10.1007/s11307-009-0245-9 ;PMID: 19543946

Full text available

12
131I-tositumomab radioimmunotherapy: initial tumor dose-response results using 3-dimensional dosimetry including radiobiologic modeling
Material Type:
Article
Add to My Research

131I-tositumomab radioimmunotherapy: initial tumor dose-response results using 3-dimensional dosimetry including radiobiologic modeling

The Journal of nuclear medicine (1978), 2010-07, Vol.51 (7), p.1155-1162 [Peer Reviewed Journal]

COPYRIGHT © 2010 by the Society of Nuclear Medicine, Inc. 2010 ;ISSN: 0161-5505 ;EISSN: 1535-5667 ;DOI: 10.2967/jnumed.110.075176 ;PMID: 20554734

Full text available

13
131I-Tositumomab Therapy as Initial Treatment for Follicular Lymphoma
Material Type:
Article
Add to My Research

131I-Tositumomab Therapy as Initial Treatment for Follicular Lymphoma

The New England journal of medicine, 2005-02, Vol.352 (5), p.441-449 [Peer Reviewed Journal]

Copyright © 2005 Massachusetts Medical Society. All rights reserved. ;2005 INIST-CNRS ;Copyright 2005 Massachusetts Medical Society. ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa041511 ;PMID: 15689582 ;CODEN: NEJMAG

Full text available

14
14th annual UCLA symposia. Monoclonal antibodies and cancer therapy. January 26-February 2, 1985. Abstracts
Material Type:
Article
Add to My Research

14th annual UCLA symposia. Monoclonal antibodies and cancer therapy. January 26-February 2, 1985. Abstracts

Journal of cellular biochemistry. Supplement., 1985, Vol.9A, p.33-74 [Peer Reviewed Journal]

ISSN: 0733-1959 ;PMID: 3856086

Full text available

15
16-Gy Low-Voltage X-ray Irradiation With Ranibizumab Therapy for AMD: 6-Month Safety and Functional Outcomes
Material Type:
Article
Add to My Research

16-Gy Low-Voltage X-ray Irradiation With Ranibizumab Therapy for AMD: 6-Month Safety and Functional Outcomes

Ophthalmic surgery, lasers & imaging retina, 2011-11, Vol.42 (6), p.468-473 [Peer Reviewed Journal]

ISSN: 2325-8160 ;EISSN: 2325-8179 ;DOI: 10.3928/15428877-20110804-01

Full text available

16
177 Lu-Lilotomab Satetraxetan Has the Potential to Counteract Resistance to Rituximab in Non-Hodgkin Lymphoma
Material Type:
Article
Add to My Research

177 Lu-Lilotomab Satetraxetan Has the Potential to Counteract Resistance to Rituximab in Non-Hodgkin Lymphoma

Journal of Nuclear Medicine, 2020-10, Vol.61 (10), p.1468-1475 [Peer Reviewed Journal]

2020 by the Society of Nuclear Medicine and Molecular Imaging. ;ISSN: 0161-5505 ;EISSN: 1535-5667 ;EISSN: 2159-662X ;DOI: 10.2967/jnumed.119.237230 ;PMID: 32245896

Full text available

17
1(st) French-Israeli International Conference on B Cells and therapeutic antibodies: October 23-25, 2011 Jerusalem, Israel
Material Type:
Article
Add to My Research

1(st) French-Israeli International Conference on B Cells and therapeutic antibodies: October 23-25, 2011 Jerusalem, Israel

mAbs, 2012-07, Vol.4 (4), p.426-433 [Peer Reviewed Journal]

EISSN: 1942-0870 ;DOI: 10.4161/mabs.20289 ;PMID: 22664457

Full text available

18
A 1-year case-control study in patients with rheumatoid arthritis indicates prevention of loss of bone mineral density in both responders and nonresponders to infliximab
Material Type:
Article
Add to My Research

A 1-year case-control study in patients with rheumatoid arthritis indicates prevention of loss of bone mineral density in both responders and nonresponders to infliximab

Arthritis research & therapy, 2007-01, Vol.9 (3), p.R61-R61 [Peer Reviewed Journal]

COPYRIGHT 2007 BioMed Central Ltd. ;Distributed under a Creative Commons Attribution 4.0 International License ;Copyright © 2007 Marotte et al.; licensee BioMed Central Ltd. 2007 Marotte et al.; licensee BioMed Central Ltd. ;ISSN: 1478-6354 ;EISSN: 1478-6362 ;DOI: 10.1186/ar2219 ;PMID: 17597527

Full text available

19
A 12-week-old male with a 10-day history of fever
Material Type:
Article
Add to My Research

A 12-week-old male with a 10-day history of fever

Pediatric annals, 2014-05, Vol.43 (5), p.e111-e115 [Peer Reviewed Journal]

Copyright 2014, SLACK Incorporated. ;Copyright 2014, SLACK Incorporated ;ISSN: 0090-4481 ;EISSN: 1938-2359 ;DOI: 10.3928/00904481-20140417-09 ;PMID: 24877492

Full text available

20
A 16-year-old girl with perianal skin tags
Material Type:
Article
Add to My Research

A 16-year-old girl with perianal skin tags

Pediatric annals, 2012-06, Vol.41 (6), p.10-12 [Peer Reviewed Journal]

Copyright 2012, SLACK Incorporated ;ISSN: 0090-4481 ;EISSN: 1938-2359 ;DOI: 10.3928/00904481-20120525-10 ;PMID: 22694227

Full text available

Results 1 - 20 of 24,062  for All Library Resources

Results 1 2 3 4 5 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Show only

  1. Peer-reviewed Journals (22,495)

Refine My Results

Creation Date 

From To
  1. Before 1989  (525)
  2. 1989 To 1996  (1,841)
  3. 1997 To 2004  (4,086)
  4. 2005 To 2013  (11,497)
  5. After 2013  (6,115)
  6. More options open sub menu

Language 

  1. English  (23,148)
  2. Japanese  (3,300)
  3. French  (314)
  4. German  (273)
  5. Spanish  (224)
  6. Portuguese  (87)
  7. Italian  (63)
  8. Russian  (32)
  9. Norwegian  (31)
  10. Polish  (30)
  11. Swedish  (23)
  12. Czech  (22)
  13. Chinese  (18)
  14. Korean  (11)
  15. Hungarian  (7)
  16. Serbian  (7)
  17. Croatian  (6)
  18. Turkish  (4)
  19. Slovak  (2)
  20. Icelandic  (2)
  21. More options open sub menu

Searching Remote Databases, Please Wait